Infectious Disease Therapeutics Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Anti-viral, Anti-bacterial, Anti-fungal, and Others), Indication (HIV, Hepatitis, Tuberculosis, Influenza, HPV, and Others), Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
The infectious disease therapeutics market was valued at US$ 119.708 billion in 2022 and is expected to reach US$ 167.883 billion by 2030. The market is estimated to register a CAGR of 4.3% from 2022 to 2030.
Infectious diseases can transfer from one person to another through direct or indirect contact. Patients must take medications with anti-infective properties to treat infectious diseases. Pathogens such as bacteria, fungi, viruses, and parasites are the primary cause of these disorders. In order to target the organism causing the sickness and implement a remedy, the host's defensive system is directly targeted. A huge geriatric population has presented a significant opportunity for the market for infectious disease therapeutics to grow in the coming years.
Research and development (R&D) is a critical part of the business of biopharmaceuticals and pharmaceutical companies. R&D enables them to launch new products with significant medical and commercial potential for several therapeutic applications.
The following are a few of the major projects that the manufacturers have funded:
By Product, Infectious Disease Therapeutics Market-Based Insights
Based on the drug type, the infectious disease therapeutics market, by drug class, is segmented into anti-viral, anti-bacterial, anti-fungal, and others. The anti-viral segment held the largest market share in 2022; the anti-bacterial segment is likely to register the highest CAGR in the infectious disease therapeutics market from 2022–2030. Anti-viral agents are drugs approved by the US Food and Drug Administration (FDA) for treating viral infections. Anti-viral agents typically target distinct phases of the viral life cycle. Anti-viral medications can be used for prevention, treatment, suppression, or overt disease.
By Indication, Infectious Disease Therapeutics Market-Based Insights
Based on the indication, the infectious disease therapeutics market is segmented into HIV, hepatitis, tuberculosis, influenza, HPV, and others. The HIV segment held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2030. HIV weakens an individual’s immune system by destroying important cells that fight disease and infection. Due to various factors, including sexual partners and risky behaviors, some groups of people in the US are more likely to contract HIV than others. The risk of getting an infection after surgery can rise due to growing immune system suppression by HIV. The number of patients with HIV infection has been steadily rising in recent years. The life expectancy of HIV infection and AIDS patients has significantly increased since the introduction of antiretroviral therapy (ART).
Healthcare-Associated Infections, the National Institute of Health, and the Centers for Disease Control and Prevention are a few of the major primary and secondary sources referred to while preparing the report on the infectious disease therapeutics market.
Infectious diseases can transfer from one person to another through direct or indirect contact. Patients must take medications with anti-infective properties to treat infectious diseases. Pathogens such as bacteria, fungi, viruses, and parasites are the primary cause of these disorders. In order to target the organism causing the sickness and implement a remedy, the host's defensive system is directly targeted. A huge geriatric population has presented a significant opportunity for the market for infectious disease therapeutics to grow in the coming years.
Research and development (R&D) is a critical part of the business of biopharmaceuticals and pharmaceutical companies. R&D enables them to launch new products with significant medical and commercial potential for several therapeutic applications.
The following are a few of the major projects that the manufacturers have funded:
- In June 2022, GSK plc invested US$ 1.21 billion (?1 billion) over ten years to accelerate R&D dedicated to infectious diseases. New investment supports innovation in malaria, tuberculosis, and HIV, with additional emphasis on Neglected Tropical Diseases and antimicrobial resistance.
- In March 2022, the decision by the Canadian government to provide US$ 48.07 million (CAD 60 million) to the Global Fund's COVID-19 Response Mechanism (C19RM) was applauded by the Global Fund to Fight AIDS, Tuberculosis, and Malaria. The additional financing will assist in providing low- and middle-income nations with life-saving diagnostic procedures, medical oxygen, and personal protective equipment (PPE).
- In September 2021, the Biden-Harris Administration announced a US$ 2.1 billion investment to enhance infection prevention and control initiatives in the US public health and healthcare sectors. In order to address state, municipal, and territorial health agencies and other partner organizations that deal with infectious diseases in the US, the Biden-Harris administration has made financial investments in US rescue programs through the Centers for Disease Control and Prevention (CDC).
By Product, Infectious Disease Therapeutics Market-Based Insights
Based on the drug type, the infectious disease therapeutics market, by drug class, is segmented into anti-viral, anti-bacterial, anti-fungal, and others. The anti-viral segment held the largest market share in 2022; the anti-bacterial segment is likely to register the highest CAGR in the infectious disease therapeutics market from 2022–2030. Anti-viral agents are drugs approved by the US Food and Drug Administration (FDA) for treating viral infections. Anti-viral agents typically target distinct phases of the viral life cycle. Anti-viral medications can be used for prevention, treatment, suppression, or overt disease.
By Indication, Infectious Disease Therapeutics Market-Based Insights
Based on the indication, the infectious disease therapeutics market is segmented into HIV, hepatitis, tuberculosis, influenza, HPV, and others. The HIV segment held the largest market share in 2022 and is anticipated to register the highest CAGR from 2022 to 2030. HIV weakens an individual’s immune system by destroying important cells that fight disease and infection. Due to various factors, including sexual partners and risky behaviors, some groups of people in the US are more likely to contract HIV than others. The risk of getting an infection after surgery can rise due to growing immune system suppression by HIV. The number of patients with HIV infection has been steadily rising in recent years. The life expectancy of HIV infection and AIDS patients has significantly increased since the introduction of antiretroviral therapy (ART).
Healthcare-Associated Infections, the National Institute of Health, and the Centers for Disease Control and Prevention are a few of the major primary and secondary sources referred to while preparing the report on the infectious disease therapeutics market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Infectious Disease Therapeutics Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. INFECTIOUS DISEASE THERAPEUTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. INFECTIOUS DISEASE THERAPEUTICS MARKET – KEY MARKET DYNAMICS
5.1 Infectious Disease Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Infectious Disease
5.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics
5.3 Market Restraints
5.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects
5.4 Market Opportunities
5.4.1 Growing Opportunities in Developing Nations
5.5 Future Trends
5.5.1 Rising Number of Product Approvals and Launches
5.6 Impact of Drivers and Restraints:
6. INFECTIOUS DISEASE THERAPEUTICS MARKET – GLOBAL MARKET ANALYSIS
6.1 Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
7. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY DRUG CLASS
7.1 Overview
7.2 Anti-Viral
7.2.1 Overview
7.2.2 Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Anti-bacterial
7.3.1 Overview
7.3.2 Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Anti-fungal
7.4.1 Overview
7.4.2 Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY INDICATION
8.1 Overview
8.2 HIV
8.2.1 Overview
8.2.2 HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hepatitis
8.3.1 Overview
8.3.2 Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tuberculosis
8.4.1 Overview
8.4.2 Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 HPV
8.6.1 Overview
8.6.2 HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Overview
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Topical
9.4.1 Overview
9.4.2 Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Retail Pharmacies
10.3.1 Overview
10.3.2 Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11. INFECTIOUS DISEASE THERAPEUTICS MARKET – GEOGRAPHICAL ANALYSIS
11.1 North America: Infectious Disease Therapeutics Market
11.1.1 Overview
11.1.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.1.2.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.1.2.4 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.2 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.2.1 Overview
11.1.3.3 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.3.1 United States: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.3.2 United States: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.3.3 United States: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.3.4 United States: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.4 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.4.1 Overview
11.1.3.5 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.5.1 Canada: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.5.2 Canada: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.5.3 Canada: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.5.4 Canada: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.6 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.6.1 Overview
11.1.3.7 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.7.1 Mexico: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.7.2 Mexico: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.7.3 Mexico: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.7.4 Mexico: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2 Europe: Infectious Disease Therapeutics Market
11.2.1 Overview
11.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.2.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.2.2.4 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.2 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.2.1 Overview
11.2.3.3 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.3.1 Germany: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.3.2 Germany: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.3.3 Germany: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.3.4 Germany: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.4 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.4.1 Overview
11.2.3.5 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.5.1 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.5.2 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.5.3 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.5.4 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.6 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.6.1 Overview
11.2.3.7 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.7.1 France: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.7.2 France: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.7.3 France: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.7.4 France: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.8 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.8.1 Overview
11.2.3.9 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.9.1 Italy: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.9.2 Italy: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.9.3 Italy: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.2.3.9.4 Italy: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.10 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.10.1 Overview
11.2.3.11 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.11.1 Spain: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.11.2 Spain: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.11.3 Spain: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.11.4 Spain: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.12 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.12.1 Overview
11.2.3.13 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.13.1 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.13.2 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.13.3 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.13.4 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3 Asia Pacific: Infectious Disease Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.2.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.3.2.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.2 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.2.1 Overview
11.3.3.3 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 China: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.3.2 China: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.3.3 China: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.3.4 China: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.4 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.4.1 Overview
11.3.3.5 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 Japan: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.5.2 Japan: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.5.3 Japan: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.5.4 Japan: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.6 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.6.1 Overview
11.3.3.7 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 India: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.7.2 India: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.7.3 India: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.7.4 India: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.8 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.8.1 Overview
11.3.3.9 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Australia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.9.2 Australia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.9.3 Australia: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.9.4 Australia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.10 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.10.1 Overview
11.3.3.11 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 South Korea: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.11.2 South Korea: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.11.3 South Korea: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.11.4 South Korea: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.12 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.12.1 Overview
11.3.3.13 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.13.1 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.13.2 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.13.3 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.13.4 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4 Middle East & Africa Infectious Disease Therapeutics Market
11.4.1 Overview
11.4.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.4.2.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.4 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.2 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 Overview
11.4.3.3 Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.3.2 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.3.3 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.3.4 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.4 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 Overview
11.4.3.5 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.5.2 South Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.5.3 South Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.5.4 South Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.6 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Overview
11.4.3.7 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.7.2 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.7.3 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.7.4 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.8 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.8.1 Overview
11.4.3.9 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.9.1 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.9.2 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.9.3 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.9.4 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5 South and Central America: Infectious Disease Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.5.2.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.4 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.2 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.2.1 Overview
11.5.3.3 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.3.1 Brazil: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.3.2 Brazil: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.3.3 Brazil: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.3.4 Brazil: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.4 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.4.1 Overview
11.5.3.5 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.5.1 Argentina: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.5.2 Argentina: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.5.3 Argentina: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.5.4 Argentina: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.6 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.6.1 Overview
11.5.3.7 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.7.1 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.7.2 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.7.3 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.7.4 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
12. INFECTIOUS DISEASE THERAPEUTICS MARKET-INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Infectious Disease Therapeutics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Pfizer Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Shionogi & Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioCryst Pharmaceuticals Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GSK Plc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AbbVie Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck & Co Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Astellas Pharma Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Infectious Disease Therapeutics Market, by Geography (US$ Million)
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. INFECTIOUS DISEASE THERAPEUTICS MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. INFECTIOUS DISEASE THERAPEUTICS MARKET – KEY MARKET DYNAMICS
5.1 Infectious Disease Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Infectious Disease
5.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics
5.3 Market Restraints
5.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects
5.4 Market Opportunities
5.4.1 Growing Opportunities in Developing Nations
5.5 Future Trends
5.5.1 Rising Number of Product Approvals and Launches
5.6 Impact of Drivers and Restraints:
6. INFECTIOUS DISEASE THERAPEUTICS MARKET – GLOBAL MARKET ANALYSIS
6.1 Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
7. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY DRUG CLASS
7.1 Overview
7.2 Anti-Viral
7.2.1 Overview
7.2.2 Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Anti-bacterial
7.3.1 Overview
7.3.2 Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Anti-fungal
7.4.1 Overview
7.4.2 Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY INDICATION
8.1 Overview
8.2 HIV
8.2.1 Overview
8.2.2 HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hepatitis
8.3.1 Overview
8.3.2 Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tuberculosis
8.4.1 Overview
8.4.2 Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 HPV
8.6.1 Overview
8.6.2 HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY ROUTE OF ADMINISTRATION
9.1 Overview
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Topical
9.4.1 Overview
9.4.2 Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10. INFECTIOUS DISEASE THERAPEUTICS MARKET ANALYSIS – BY DISTRIBUTION CHANNEL
10.1 Overview
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Retail Pharmacies
10.3.1 Overview
10.3.2 Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11. INFECTIOUS DISEASE THERAPEUTICS MARKET – GEOGRAPHICAL ANALYSIS
11.1 North America: Infectious Disease Therapeutics Market
11.1.1 Overview
11.1.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.1.2.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.1.2.4 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.2 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.2.1 Overview
11.1.3.3 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.3.1 United States: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.3.2 United States: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.3.3 United States: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.3.4 United States: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.4 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.4.1 Overview
11.1.3.5 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.5.1 Canada: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.5.2 Canada: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.5.3 Canada: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.5.4 Canada: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.6 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.6.1 Overview
11.1.3.7 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.7.1 Mexico: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.7.2 Mexico: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.7.3 Mexico: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.7.4 Mexico: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2 Europe: Infectious Disease Therapeutics Market
11.2.1 Overview
11.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.2.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.2.2.4 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.2 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.2.1 Overview
11.2.3.3 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.3.1 Germany: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.3.2 Germany: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.3.3 Germany: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.3.4 Germany: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.4 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.4.1 Overview
11.2.3.5 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.5.1 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.5.2 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.5.3 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.5.4 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.6 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.6.1 Overview
11.2.3.7 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.7.1 France: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.7.2 France: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.7.3 France: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.7.4 France: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.8 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.8.1 Overview
11.2.3.9 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.9.1 Italy: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.9.2 Italy: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.9.3 Italy: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.2.3.9.4 Italy: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.10 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.10.1 Overview
11.2.3.11 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.11.1 Spain: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.11.2 Spain: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.11.3 Spain: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.11.4 Spain: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.12 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.12.1 Overview
11.2.3.13 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.13.1 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.13.2 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.13.3 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.13.4 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3 Asia Pacific: Infectious Disease Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.2.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.3.2.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.2 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.2.1 Overview
11.3.3.3 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 China: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.3.2 China: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.3.3 China: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.3.4 China: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.4 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.4.1 Overview
11.3.3.5 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 Japan: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.5.2 Japan: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.5.3 Japan: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.5.4 Japan: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.6 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.6.1 Overview
11.3.3.7 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 India: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.7.2 India: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.7.3 India: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.7.4 India: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.8 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.8.1 Overview
11.3.3.9 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Australia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.9.2 Australia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.9.3 Australia: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.9.4 Australia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.10 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.10.1 Overview
11.3.3.11 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 South Korea: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.11.2 South Korea: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.11.3 South Korea: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.11.4 South Korea: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.12 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.12.1 Overview
11.3.3.13 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.13.1 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.13.2 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.13.3 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.13.4 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4 Middle East & Africa Infectious Disease Therapeutics Market
11.4.1 Overview
11.4.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.4.2.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.4 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.2 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 Overview
11.4.3.3 Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.3.2 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.3.3 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.3.4 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.4 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 Overview
11.4.3.5 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.5.2 South Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.5.3 South Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.5.4 South Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.6 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Overview
11.4.3.7 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.7.2 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.7.3 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.7.4 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.8 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.8.1 Overview
11.4.3.9 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.9.1 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.9.2 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.9.3 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.9.4 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5 South and Central America: Infectious Disease Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.5.2.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.4 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.2 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.2.1 Overview
11.5.3.3 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.3.1 Brazil: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.3.2 Brazil: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.3.3 Brazil: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.3.4 Brazil: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.4 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.4.1 Overview
11.5.3.5 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.5.1 Argentina: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.5.2 Argentina: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.5.3 Argentina: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.5.4 Argentina: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.6 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.6.1 Overview
11.5.3.7 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.7.1 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.7.2 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.7.3 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.7.4 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
12. INFECTIOUS DISEASE THERAPEUTICS MARKET-INDUSTRY LANDSCAPE
12.1 Overview
12.2 Growth Strategies in the Infectious Disease Therapeutics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. COMPANY PROFILES
13.1 Pfizer Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Shionogi & Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioCryst Pharmaceuticals Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GSK Plc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AbbVie Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck & Co Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Astellas Pharma Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Infectious Disease Therapeutics Market Segmentation
Table 2. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Drug Class
Table 3. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Indication
Table 4. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 5. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 6. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 7. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 8. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 10. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 12. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 13. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$
Table 1. Infectious Disease Therapeutics Market Segmentation
Table 2. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Drug Class
Table 3. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Indication
Table 4. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 5. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 6. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 7. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 8. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 10. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 12. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 13. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$
